tradmap

FOCL EDAP TMS SA

$4.29 -0.46%

Data as of close

Healthcare · Electromedical & Electrotherapeutic Apparatus

EDAP TMS SA (FOCL) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $161 million. Shares last traded at $4.29. Net profit margin is -41.5%, below the peer median of -10.0%. Revenue grew 1.6% year over year.

Market Cap
$161M
Shares Out
37.5M
EPS (TTM)
-$0.78
P/E (TTM)*
—
P/S Ratio
2.28
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
—
52-Week Low
—
Volume (venue)
202
Avg Vol (3m, venue)
4,343.889

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+1.18%
1M
+0.94%
3M
-29.21%
6M
—
YTD
-5.71%
1Y
—

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.25
SMA (50)
$4.27
SMA (200)
—
Price vs SMA50
+0.54%
Price vs SMA200
—
ATR (14)
$0.15

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$71M
Net Income
-$29M
Gross Margin
42.5%
Operating Margin
-35.0%
Net Margin
-41.5%
Return on Equity
—
Return on Assets
-39.2%
Current Ratio
1.60
Debt / Equity
—
Revenue Growth (YoY)
+1.6%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.39 2026-08-14
Q1 2026 -$0.24 2026-05-07
FY 2025 -$0.78 2026-03-25
Q2 2025 -$0.17 —
Q1 2025 -$0.20 —
FY 2024 -$0.55 —

Full earnings history →

Electromedical & Electrotherapeutic Apparatus peers

FOCL vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap. Data as of close

P/S vs peers
2.28 / 2.43 med
-6% discount
Net margin vs peers
-41.5% / -10.0% med
below median
1–14 of 14
MDTMedtronic$134.4B25.693.5813.9%+6.22%
LIVNLivanova Plc$5.2B26.473.4413.0%+17.67%
ITGRInteger Holdings Corp$4.3B41.522.365.7%+0.02%
AXGNAxogen, Inc.$3.1B—11.49-12.0%+3.67%
TMDXTransmedics Group, Inc.$2.5B16.623.7722.7%+7.85%
CNMDConmed Corp$1.6B34.011.163.4%+13.41%
CBLLCeribell, Inc.$1.1B—9.76-68.0%-3.50%
INMDInmode Ltd.$899M9.582.4325.3%+0.67%
CVCapsoVision, Inc$345M———+2.91%
ELMDElectromed, Inc.$234M20.703.1715.3%+4.25%
FOCLEDAP TMS SA$161M—2.28-41.5%-0.46%
VANIVivani Medical, Inc.$97M———+1.42%
STXSStereotaxis, Inc.$96M—3.18-74.2%+12.13%
NRXSNeuraxis, INC$86M———+2.94%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.